MAN2B1 and invasive breast carcinoma: Elevated expression of MAN2B1 has been found in several cancers, including bladder urothelial carcinoma, breast invasive carcinoma, colon adenocarcinoma, glioblastoma multiforme, low-grade gliomas, and laryngeal cancer (96, 97).